Klaribin 125 mg/5 ml , 250 mg/5 ml Suspension
PDF Leaflet Revision Date: 28 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderately severe infections.
Dosage (summary)
Adults: 250 mg twice daily; may increase to 500 mg for severe infections.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; excreted in breast milk.
Key Drug Interactions
- Warfarin
- Digoxin
- Simvastatin
- Rifabutin
- Theophylline
Contraindications
- Hypersensitivity to macrolides
- Concomitant use with astemizole
- Porphyria
Common side effects
- Nausea
- Vomiting
- Diarrhea
- Headache
- Rash
Counselling Points
- Take with or without food
- Monitor for signs of hepatic dysfunction
- Report any allergic reactions
Serious warnings
- Hepatic dysfunction
- QT prolongation
- Rhabdomyolysis risk
Important Disclaimer
The Klaribin 125 mg/5 ml , 250 mg/5 ml Suspension professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
